Suchergebnisse - "Luo, Linfeng"

PubPharm (19)

1

Differences in Clinical Profiles and Outcomes Between Early-onset and Older Patients Hospitalized for Coronary Artery Disease: A Prospective Cohort Study.

enthalten in: ResearchSquare.com | 2024

von Shali, S. | Yao, K. | Luo, L. | +12

2

Neoadjuvant-Adjuvant vs Neoadjuvant-Only PD-1 and PD-L1 Inhibitors for Patients With Resectable NSCLC : An Indirect Meta-Analysis

enthalten in: JAMA network open | 2024

von Zhou, Y. | Li, A. | Yu, H. | +8

3

STK11/LKB1-Deficient Phenotype Rather Than Mutation Diminishes Immunotherapy Efficacy and Represents STING/Type I Interferon/CD8+ T-Cell Dysfunction in NSCLC

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2023

von Li, A. | Wang, Y. | Yu, Z. | +13

CommentIn: J Thorac Oncol. 2023 Nov;18(11):e134-e135. - PMID 37879772

4

Deciphering transcriptomic determinants of the divergent link between PD-L1 and immunotherapy efficacy

enthalten in: NPJ precision oncology | 2023

von Li, A. | Luo, L. | Du, W. | +10

5

Machine learning-based risk model incorporating tumor immune and stromal contexture predicts cancer prognosis and immunotherapy efficacy

enthalten in: iScience | 2023

von He, L. | Li, H. | Du, W. | +18

6

Cuproptosis-related immune gene signature predicts clinical benefits from anti-PD-1/PD-L1 therapy in non-small-cell lung cancer

enthalten in: Immunologic research | 2023

von Luo, L. | Li, A. | Fu, S. | +8

7

Continuation of anti-PD-1 therapy plus physician-choice treatment beyond first progression is not associated with clinical benefit in patients with advanced non-small cell lung cancer

enthalten in: Frontiers in immunology | 2023

von Wang, Y. | Fu, S. | Zhang, X. | +11

8

LRRC3B and its promoter hypomethylation status predicts response to anti-PD-1 based immunotherapy

enthalten in: Frontiers in immunology | 2023

von Luo, L. | Fu, S. | Du, W. | +5

9

Tumor response assessment by measuring the single largest lesion per organ in advanced non-small cell lung cancer patients treated with PD-1/PD-L1 inhibitor

enthalten in: Therapeutic advances in medical oncology | 2023

von He, L. | Chen, T. | Fu, S. | +16

10

Indigenous earthworms and gut bacteria are superior to chemical amendments in the remediation of cadmium-contaminated seleniferous soils

enthalten in: Ecotoxicology and environmental safety | 2022

von Yang, R. | Luo, L. | Zhao, N. | +6